Ilaria Colombo

16PUBLICATIONS
83CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 20, 2026
Comparative analysis of ovarian cancer tumor-infiltrating T cells with those in melanoma and before and after PD-1 blockade.

|Jul 24, 2026
Predictive biomarkers for immunotherapy response in endometrial cancer: current insights and future directions.

|May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.

|Jan 12, 2026
Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Nov 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).

Marian Klose, Ilaria Colombo, Katrin Gobat

|Nov 10, 2025
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities.

Sara Parola, Ilaria Colombo

Pageof 3

Frequent Collaborators

3 joint publications

Cristiana Sessa

3 joint publications

Maria Del Grande

3 joint publications

Amit M Oza

2 joint publications

Federica Martorana